Traction Devices May Not Affect the Vertical Margin Distance in the Endoscopic Submucosal Dissection of Rectal Neuroendocrine Tumors
- PMID: 38800345
- PMCID: PMC11127712
- DOI: 10.7759/cureus.58976
Traction Devices May Not Affect the Vertical Margin Distance in the Endoscopic Submucosal Dissection of Rectal Neuroendocrine Tumors
Abstract
Introduction The usefulness of traction devices (TDs) in endoscopic submucosal dissection (ESD) for rectal neuroendocrine tumors (NETs) has not been reported. The aim of this study was to investigate the impact of using a TD on the vertical margin (VM) distance in the ESD of rectal NETs. Methods In this single-center, retrospective study, we included patients with rectal NETs who were treated with ESD during 2013-2023. They were divided into TD and non-TD groups. One pathologist remeasured the VM distance (primary outcome) and the depth of submucosal invasion (SM depth). Secondary outcomes were margins, resection time, delayed bleeding, and perforation. First, we performed propensity score matching (PSM) to assess the usefulness of TD for VM distance. Then, we used multiple regression analysis to identify factors affecting the VM distance. Results The TD and non-TD groups comprised 24 and 117 lesions, respectively. Patients in the TD group were significantly younger than those in the non-TD group (P = 0.003). In the TD and non-TD groups, the VM distance was 150 μm and 100 μm, respectively (P = 0.70). Only resection time significantly differed between groups, shorter in the TD group (P = 0.005). Twenty-two cases in each group were matched after PSM, yielding no significant differences in VM distance. The use of a TD was not an independent predictor of VM distance (P = 0.65), but age (P < 0.001) and SM depth (P = 0.003) were. Conclusion Using a TD does not seem to affect the VM distance in ESD for rectal NETs.
Keywords: endoscopic submucosal dissection; neuroendocrine tumor; rectum; traction device; vertical margin.
Copyright © 2024, Hayasaka et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Clinical outcomes of endoscopic resection for rectal neuroendocrine tumors: Advantages of endoscopic submucosal resection with a ligation device compared to conventional EMR and ESD.DEN Open. 2021 Sep 1;2(1):e35. doi: 10.1002/deo2.35. eCollection 2022 Apr. DEN Open. 2021. PMID: 35310732 Free PMC article.
-
[Application of dental floss traction-assisted endoscopic submucosa dissection to rectal neuroendocrine neoplasm].Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):377-382. doi: 10.3760/cma.j.issn.1671-0274.2019.04.011. Zhonghua Wei Chang Wai Ke Za Zhi. 2019. PMID: 31054553 Chinese.
-
Comparison of endoscopic therapies for rectal neuroendocrine tumors: endoscopic submucosal dissection with myectomy versus endoscopic submucosal dissection.Surg Endosc. 2021 Nov;35(11):6374-6378. doi: 10.1007/s00464-021-08622-8. Epub 2021 Jul 6. Surg Endosc. 2021. PMID: 34231072
-
Endoscopic submucosal dissection versus endoscopic mucosal resection for rectal carcinoid tumor. A meta-analysis and meta-regression with single-arm analysis.J Dig Dis. 2021 Oct;22(10):562-571. doi: 10.1111/1751-2980.13048. J Dig Dis. 2021. PMID: 34472210 Review.
-
AGA Institute Clinical Practice Update: Endoscopic Submucosal Dissection in the United States.Clin Gastroenterol Hepatol. 2019 Jan;17(1):16-25.e1. doi: 10.1016/j.cgh.2018.07.041. Epub 2018 Aug 2. Clin Gastroenterol Hepatol. 2019. PMID: 30077787 Review.
Cited by
-
Current status of endoscopic resection for small rectal neuroendocrine tumors.World J Gastroenterol. 2025 May 21;31(19):106814. doi: 10.3748/wjg.v31.i19.106814. World J Gastroenterol. 2025. PMID: 40497093 Free PMC article. Review.
References
-
- One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Yao JC, Hassan M, Phan A, et al. J Clin Oncol. 2008;26:3063–3072. - PubMed
-
- Examining rectal carcinoids in the era of screening colonoscopy: a surveillance, epidemiology, and end results analysis. Taghavi S, Jayarajan SN, Powers BD, Davey A, Willis AI. Dis Colon Rectum. 2013;56:952–959. - PubMed
-
- Neuroendocrine neoplasms of rectum: A management update. Bertani E, Ravizza D, Milione M, et al. Cancer Treat Rev. 2018;66:45–55. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous